Teva Pharmaceutical (TEVA) Buy, Sell or Hold

Teva Pharmaceutical (TEVA)

39.59

+0.06 (0.15%)

as of Oct 5, 2026, 7:17:28 pm Market Open.

71 watching

TRADE

Primarily involved in the generic pharmaceuticals. Well managed company. Have to be very conscious of the price. A lot of patents are coming off now which is affording an opportunity to the generic companies.

Wealthica Track your Stocks in your Watch List

STRONG BUY

Has been a very strong performer. The leading global generic drug company. Stock has gone sideways this year, but 2006/2007 it will be back to some pretty hefty growth levels.

TOP PICK

An Israeli company with most of their operations and sales in North America and Europe. A generic drug producer.

BUY

Pharmaceutical sector did very poorly over the last 2 years, but deceleration in revenue growth has slowed and profitability has started to improve. Look for the strongest perfoming stock in the sector. As Eli Lilly (LLY-N) is performing better, that would be the better of the 2, but would suggest you look at Sanofi-Aventis (SNY-N) which is close to new highs and Teva Pharmaceuticals (TEVA-Q) in generics.

DON'T BUY

Prefers others.

BUY

One of the world's largest genetic drug manufactor company. The stock has dropped in the last few weeks. This is a good opportunity to buy stocks.

TOP PICK

Wonderful company. Not overvalued.

BUY ON WEAKNESS

Generic drugs is a great sector. This one is the leader. Accumulate on a gradual basis.

HOLD

Generic drug space is a good place to be. A little high now.

TOP PICK

Generic drugs have done very well. Have increased their margins regularily. Steadily moving up.

BUY

Good growth trend. Good products. May drop in the near term.

TOP PICK

Likes the generic drug sector.

PAST TOP PICK

(Was a top pick on Aug 23. Up 1%) Still likes. Likess the generic sector in drugs.

TOP PICK

Stable revenue stream and earnings record. Likes the generic drug sector.

PAST TOP PICK

(Was a top pick on Mar 15. Up 19%.) Still likes.

Showing 256 to 270 of 279 entries

Most Recent Experts

Mike Vinokur, CFA, CMT, and CFP

Propellus Wealth Partners/iA Private Wealth

Bruce Murray

The Murray Wealth Group

Dennis Mitchell, CFA

Sentry Select Capital Corp

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Teva Pharmaceutical (TEVA)